Regenerative Medicine Market (By Product: Gene Therapies, Cell Therapies, Tissue-Engineering, Progenitor and Stem Cell Therapies, and Others; By Application: Wound Care, Musculoskeletal, Ophthalmology, Oncology, Cardiovascular, and Others) - Global Industry Analysis, Market Size, Share, Growth, Trends, Regional Outlook and Forecasts 2022 - 2030

The global regenerative medicine market size was valued at USD 20.04 billion in 2021 and is predicted to be worth around USD 125.54 billion by 2030 with a CAGR of 16.2% from 2022 to 2030.

Key Takeaway:

• By product, the cell therapy segment garnered highest revenue share of around 57.7% in 2021.
• Tissue engineering product segment accounted 28.3% revenue share in 2021.
• By therapeutic category, the oncology segment captured revenue share of over 32% in 2021.
• North America region hit revenue share of over 49.1% in 2021.

Key market Insights:

Stem cell therapy is one of the most revolutionary applications of regenerative medicine in the real-world scenario.  Stem cell therapy encourages the repair response of ailing, dysfunctional or wounded tissue by means of stem cells or their by products. It is the next big thing in organ transplantation and makes use of cells in the place of donor organs, that are limited in stock. Scientists cultivate stem cells in a laboratory. These stem cells are operated to specialize into particular cells, such as blood cells, heart muscle or nerve cells. The specific cells can then be implanted into an individual. Stem cells have the capability to build all tissue in the human body, therefore have great possibility for future healing uses in tissue repair and regeneration.

Crucial factors accountable for market growth are:

• Increasing prevalence of chronic ailments
• Growing incidence of genetic disorders
• Rapidly increasing trauma cases
• Growing investment in research and development for regenerative medicine
• Strong product pipeline of regenerative medicine products
• Increasing popularity of stem cell therapy

Report Scope of the Regenerative Medicine Market

Significant Market Trends:

Tissue-Engineering Segment Reported Foremost Market Stake in 2021

Tissue-Engineering segment recorded the prime market share in the global regenerative medicine Market in 2021. The key reason for the hefty share of the tissue-engineering segment is multiple advantages such as ability to replace a defective structure with an entirely living structure and potential in developing treatments for previously untreatable medical conditions. Moreover, high investment in research and development for developing effective treatments, and constant launch of new and effective products are expected to boost the demand in tissue engineering segment.

The stem cell therapies segment is projected grow at the highest CAGR during the forecast period mainly due to increasing popularity of stem cell related treatment options and high investment by major manufacturers. Other factors responsible for high growth of stem cells therapy segment are increasing geriatric population, and increasing trauma cases worldwide.

• The cell therapy segment was accounted at USD 7,051.7 million in 2020 and to reach at a CAGR of 22.2% from 2022 to 2030.
• The gene therapy segment size was estimated at USD 993.4 million in 2020 and growing at a CAGR of 23.1% over the forecast period 2022 to 2030.

Musculoskeletal Applications are Projected to Dominate the Regenerative Medicine Market Revenue

Regenerative medicine, specifically cellular therapy, is a rapidly emerging field that is being explored as a possibility for the repair of function in numerous disease areas including musculoskeletal ailments. High research and development activity in use of regenerative medicine for the treatment of musculoskeletal disorders is the major reason for the high revenue share of regenerative medicines.

Oncology segment will hold a significant share in the global regenerative medicine market mainly due to the high incidence of cancer globally and increasing demand for development of new technologies for the treatment of cancer.

• The musculoskeletal segment was worth around USD 4,053.1 million in 2020 and is growing at a CAGR of 22.5% from 2022 to 2030.
• The wound healing segment size was estimated at USD 3,461 million in 2020 and growing at a CAGR of 23.2% over the forecast period 2022 to 2030.
• The oncology segment was worth around USD 1,459.5 million in 2020 and is growing at a CAGR of 22.9% from 2022 to 2030.
• The dermatology segment was valued at USD 788.1 million in 2020 and growing at a CAGR of 22.1% over the forecast period 2022 to 2030.

Global Regenerative Medicine Market Revenue Share, By Region, 2021 (%)

North America is Estimated to be the Largest Market for Regenerative Medicine

The research report covers key trends and prospects of regenerative medicine products across different geographical regions including North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Geographically, regenerative medicine market is conquered by North America owing to high incidence of chronic diseases and presence of sophisticated healthcare framework. On the other hand, Asia-Pacific is anticipated to witness the rapid growth rate, on account of increasing healthcare expenditure and growing investment by major manufactures to launch new products.

• North America regenerative medicine market size was valued at USD 5,990.8 million in 2020 and is growing at a CAGR of 22.2% during 2022 to 2030.
• The Asia Pacific market was reached at USD 1,549 million in 2020 and is growing at a registered CAGR of 26.6% from 2022 to 2030.

Top Players contending in the Market:

The companies focusing on research and development are expected to lead the global regenerative medicine market. Leading competitors contending in global regenerative medicine market are as follows:

• Integra LifeSciences Corporation
• Aspect Biosystems
• Amgen, Inc.
• Medtronic plc
• AstraZeneca
• Novartis AG
• Smith & Nephew plc
• MiMedx Group
• Shenzhen SibionoGeneTech Co., Ltd.
• Baxter

In order to better recognize the current status of regenerative medicine, and policies adopted by the foremost countries, Precedence Research predicted the future evolution of the regenerative medicine market. This research study bids qualitative and quantitative insights on regenerative medicine market and assessment of market size and growth trend for potential market segments.

Major Market Segments Covered:

By Product

• Gene Therapies
• Cell Therapies
• Tissue-Engineering
• Progenitor and Stem Cell Therapies
• Others

By Material

• Synthetic material
  • Scaffold
  • Artificial vascular graft material
  • Hydrogel material
• Biologically derived material
  • Collagen
  • Xenogeneic material
• Genetically Engineered Material
  • Genetically Manipulated Cell
  • Three-Dimensional Polymer Technology
  • Transgenics
  • Fibroblast
  • Neural Stem Cell
  • Gene-Activated Matrices
• Pharmaceutical
  • Biologic

By Application

• Wound Care
• Musculoskeletal
• Ophthalmology
• Oncology
• Cardiovascular
• Others

By End User

• Hospitals & Clinics
• Commercial Industries
• Government & Academic Research Institutes

By Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa